Assessment of chromosomal losses and gains in hepatocellular carcinoma
Authors:
- Zhe PiaoZPZhe Piao
- Hoguen KimHKHoguen Kim
- 1 August 2002
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 182 (2) , 193-202
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- p16 is a major inactivation target in hepatocellular carcinomaCancer, 2000
- Genetic Aberrations Detected by Comparative Genomic Hybridization in Hepatocellular Carcinomas: Their Relationship to Clinicopathological FeaturesHepatology, 1999
- Assessment of Genetic Changes in Hepatocellular Carcinoma by Comparative Genomic Hybridization AnalysisThe American Journal of Pathology, 1999
- Infrequent mutations and no methylation of CDKN2A (p16/MTS1) and CDKN2B (p15/MTS2) in hepatocellular carcinoma in TaiwanEuropean Journal of Cancer, 1998
- Allelotype analysis of hepatocellular carcinomaInternational Journal of Cancer, 1998
- Homozygous deletions of the CDKN2 gene and loss of heterozygosity of 9p in primary hepatocellular carcinomaCancer Letters, 1998
- Molecular mechanism of hepatocarcinogenesisJournal of Gastroenterology and Hepatology, 1997
- Comprehensive allelotyping of human hepatocellular carcinomaOncogene, 1997
- Recurrent chromosomal abnormalities in hepatocellular carcinoma detected by comparative genomic hybridizationGenes, Chromosomes and Cancer, 1997
- Evidence for the presence of two tumour-suppressor genes for hepatocellular carcinoma on chromosome 13qBritish Journal of Cancer, 1995